No Detail Found!

Serum Level of Indolamine 2, 3-Dioxygenase as a Marker in the Evaluation of Atopic Asthma

Author(s)
Maged Mohamed Refaat Department of Internal Medicine, Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University,Cairo,Egypt
Asmaa Saber Abdel Rehim Department of Internal Medicine, Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University,Cairo,Egypt
Osama Mohamed Abdel Latif Department of Internal Medicine, Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University,Cairo,Egypt
Nesrine Aly Mohamed Department of Clinical Pathology, Faculty of Medicine, Ain Shams University,Cairo,Egypt
Ahmad Talat Faheem Department of Internal Medicine, Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University,Cairo,Egypt
Abstract
BACKGROUND: The changes in amino acid catabolism contribute to the regulation of immune system. The role of indoleamine 2,3-dioxygenase (IDO), and enzyme that mediates the catabolism of tryptophan (trp), remains a controversy. The aim of this study was to determine the relationship between serum level of IDO and the extent of asthma control in patients with allergic bronchial asthma. METHODS: This was a cross-sectional study enrolling 40 atopic patients with allergic bronchial asthma; 20 patients with controlled asthma and 20 patients with uncontrolled asthma. Asthma diagnosis and the level of asthma severity and control were established according to The Global Initiative for Asthma (GINA) recommendations 2012. Atopy was defined by the presence of at least one positive skin prick test reaction to common environmental allergens. Total serum immunoglobulin E (IgE) and serum IDO concentration were measured in all patients. Twenty healthy individuals were included in this study to determine the cutoff level of serum IDO. We used unpaired t-test and Fisher’s exact test for determining statistical significance. RESULTS: Serum IDO levels were significantly different across the three study groups (p<0.001). Uncontrolled asthma and controlled asthma patients had significantly higher median (IQR) level of IDO [1200 (975-1950), 1000 (762.5-1650) respectively] compared to controls [300 (150-300)]. On the other hand, serum IDO level did not differ significantly between uncontrolled and controlled asthma patients. CONCLUSION: Atopic patients with bronchial asthma have high serum IDO levels. There is no relationship between IDO levels and asthma control.
Publication Details
Page(s) 73-76
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 6, Issue: 3, Year: 2016

Request the full text from PASTIC

Keywords
Asthma, Allergic Asthma, Immunoglobulin E (IgE), Allergy, Adult Asthma, Total IgE, Atopy
References
Pietras T,Panek M,Tworek D,Oszajca K,Wujcik R,Górski P .2011 .The Bcl I single nucleotide polymorphism of the human glucocorticoid receptor gene h-GR/NR3C1 promoter in patients with bronchial asthma: pilot study. Mol Biol Rep, 38 : 3953-3958.
Fallarino F,Grohmann U .2012 .Indoleamine 2,3- dioxygenase: from catalyst to signaling function. Eur J Immunol, 42(8) : 1932-1937.
Beutelspacher SC,Tan PH,McClure MO,Larkin DF,Lechler RI,George AJ .2006 .- dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant, 6(6) : 1320-1330.
Xu H,Oriss TB,Fei M,Henry AC,Melgert BN,Chen L .2008 .-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc Natl Acad Sci USA, 105(18) : 6690-6695.
Global . .Re port_March13_1. , : .
Von Bubnoff D,Bieber T. .2012 .The indoleamine 2,3- dioxygenase (IDO) pathway controls allergy. Allergy, 67(6) : 718-725.
Odemuyiwa SO,Ghahary A,Li Y,Puttagunta L,Lee JE,Musat-Marcu S .2004 .Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol, 173(10) : 5909-5913.
Grohmann U,Volpi C,Fallarino F,Bozza S,Bianchi R,Vacca C .2007 .Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med, 13(5) : 579-586.
Honkanen T,Luukkainen A,Lehtonen M,Paavonen T,Karjalainen J,Hurme M .2011 .- dioxygenase expression is associated with chronic rhinosinusitis with nasal polyps and antrochoanal polyps. Rhinology, 49(3) : 356-363.
Von Bubnoff D,Fimmers R,Bogdanow M,Matz H,Koch S,Bieber T. .2004 .Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy, 34(7) : 1056-1063.
Hayashi T,Beck L,Rossetto C,Gong X,Takikawa O,Takabayashi K .2004 .Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest, 114(2) : 270-279.
Maneechotesuwan K,Supawita S,Kasetsinsombat K,Wongkajornsilp A,Barnes PJ .2008 .-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids. J Allergy Clin Immunol, 121(1) : 43-50.
Ciprandi G,De Amici M,Tosca M,Fuchs D .2010 .Tryptophan metabolism in allergic rhinitis: the effect of pollen allergen exposure. Hum Immunol, 71(9) : 911-915.
Mellor .2005 .A. Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Biochem Biophys Res Commun, 338(1) : 20-24.
0

Citations

0

Downloads

11

Views